Mackaness James H's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Dec 13, 2023
- Accession no.
- 0001209191-23-058576
- Filed
- Dec 13, 2023
- Trade date
- Dec 11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.18M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mackaness James HCIK 0001422484 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | MOption exerciseAcquired | +15,000 | $2.60 | +$39,000 | 44,610 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −6,252 | $35.49 | −$221,883.48 | 38,358 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −12,381 | $36.16 | −$447,696.96 | 25,977 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −13,849 | $37.06 | −$513,243.94 | 12,128 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 5,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.